The central region of the primate retina is called the macula. The fovea is located at the center of the macula, where the photoreceptors are concentrated to create a neural network adapted for high visual acuity. Damage to the fovea, e.g., by macular dystrophies and age-related macular degeneration, can reduce central visual acuity. The molecular mechanisms leading to these diseases are most likely dependent on the proteins in the macula which differ from those in the peripheral retina in expression level. To investigate whether the distribution of proteins in the macula is different from the peripheral retina, proteomic analyses of tissues from these two regions of cynomolgus monkeys were compared. Two-dimensional gel electrophoresis and mass spectrometry identified 26 proteins that were present only in the macular gel spots. The expression levels of five proteins, cone photoreceptor specific arrestin-C, g-synuclein, epidermal fatty acid binding protein, tropomyosin 1α chain, and heterogeneous nuclear ribonucleoproteins A2/B1, were significantly higher in the macula than in the peripheral retina. Immunostaining of macula sections by antibodies to each identified protein revealed unique localization in the retina, retinal pigment epithelial cells and the choroidal layer. Some of these proteins were located in cells with higher densities in the macula. We suggest that it will be important to study these proteins to determine their contribution to the pathogenesis and progression of macula diseases.
Introduction
The macula is an oval-shaped, highly pigmented spot near the central region of the primate retina. It is approximately 2.0 mm in diameter in humans [31] and 1.0 mm in macaque monkeys [36] [37] [38] . The fovea is located at the center of macula where the retinal thickness is reduced to approximately 0.1 mm and consists of only the retinal pigment epithelium (RPE), photoreceptor layer, external limiting membrane, outer nuclear layer, outer plexiform layer, and inner limiting membrane [30] . The cone density in the foveal pit is the highest in the retina, and rods, retinal ganglion cells (RGCs), and blood vessels are not present. These cones are connected to large numbers of RGCs, which are highly dense at the parafovea [31] . The cone-dense fovea mediates highacuity central vision, and any damage to the macula can lead to severely depressed central visual acuity as observed in patients with macular dystrophies and agerelated macular degeneration (AMD).
Because of the unique cellular organization of the macula, investigators have performed comprehensive gene expression studies of the macula and peripheral retina using DNA microarray analysis or Serial Analysis of Gene Expression (SAGE). Sharon et al. used SAGE to show that several genes are preferentially expressed in the human macula and RPE. Most of these genes are associated with the function of the RGCs, and were presumably detected because of the high density of RGCs in the macula [35] . Bowes Rickman et al. also performed SAGE on human retinas and isolated RPE cells and identified genes that are abundantly expressed in cones, RGCs, and RPE cells [3] . Ishibashi et al. performed 4 K DNA microarray analysis on RPE cells from the macula and reported five differentially expressed genes which were confirmed by real-time PCR [18] . Recently, Radeke et al. [32] and van Soest et al. [48] used 22 K DNA microarray analyses and identified a number of genes that were differentially expressed in the macula and peripheral retina. In each study, five of these genes were found to be highly expressed in RPE cells in the macula. van Soest et al. showed by immunohistochemistry that the WAP four-disulfide core domain 1, one of the highly expressed proteins, is present in the RPE cells in the macula. However, the expression level of the mRNAs does not always correlate with the expression levels of the proteins.
Recent technical advances in proteomics allow the direct determination of the protein profile of body fluids and tissue homogenates. Proteomic analyses of the retina were first performed by Nishizawa et al. [28] , and several groups have catalogued the retinal proteins using single or two-dimensional (2D) gel electrophoresis followed by mass spectrometry (MS) analysis [1, 5, 50] . Ethen et al. examined cadaver eyes with AMD by proteomic analyses and reported that the expression of proteins changed with the progression of AMD, and the changes in the macula were different from those in the peripheral retina [10] . These findings indicate that the macular region of the retina is different from the peripheral retina not only in its morphology but also in its protein content.
Proteomic studies of the macula are difficult to perform because of the lack of fresh human eyes, and small sample size of the macula. To overcome these problems, we selected non-human primate eyes of the cynomolgus monkey (Macaca fascicularis). The retina and visual system of macaque monkeys are quite similar to those of humans [14, 29] , and monkeys with characteristics of macular diseases have been reported by many investigators [9, 16, 19, 25, 39, 40] as well as our previous studies [26, 27, [44] [45] [46] [47] . Thus, the purpose of this study was to identify proteins present at high levels in the macula to better understand the biology of this unique tissue. To accomplish this task, we performed proteomic analyses on retinal tissues obtained from the macular region and the periphery for comparison.
Materials and Methods

Preparation of cynomolgus monkey eyes
All experiments on monkeys were approved by the Animal Ethics Committee of the Tsukuba Primate Research Center (TPRC) and were conducted in accordance with The Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. Eight eyes from eight normal female cynomolgus monkeys (Macaca fascicularis) whose ages ranged between 13 to 19 years were studied. Eyes were removed approximately one hour after death and treated with RNAlater (Applied Biosystems, Tokyo, Japan). Other tissues from these animals were used by other research groups at the TPRC. Threemillimeter-diameter pieces of macular and peripheral retina containing neural retina, RPE and choroidal layer were punched out and frozen until use. The proteins extracted from the tissues of eight eyes were pooled for the analyses.
Protein extraction and 2D-gel electrophoresis
The proteins from the macula and peripheral retina were extracted after homogenization and sonication in sample buffer [7 M urea, 2 M thiourea, 4% CHAPS, 50 mM DTT, 40 mM Tris, 0.2% Bio-Lyte 3/10 (Bio-Rad, Hercules, CA, USA)]. After centrifugation for 15 min × 3 at 14,000 rpm (20,800 × g), the supernatant was collected. The lysate was precipitated using Ready Prep 2D cleanup kit (Bio-Rad) and redissolved in sample buffer. The protein concentration was determined with the RC-DC protein assay kit (Bio-Rad) according to the manufacturer's instruction. Protein samples (300 µg) were separated by isoelectric focusing (IEF) using 17-cm immobilized pH gradient (IPG) strips. After 12 to 16 h of rehydration at 20°C, the IEF sample was used for the first dimension with an initial voltage of 250 V for 15 min and then increased to 10,000 V for 3 h and held until 60,000 V-h was reached. Immediately after the IEF, the IPG strips were stored at -20°C until the equilibration step was carried out. The IPG strips were equilibrated for 20 min in buffer containing 6 M urea, 2% SDS, 0.375 M Tris (pH 8.8), and 20% glycerol under reduced conditions with 2% DTT, followed by another incubation for 10 min in the same buffer under alkylating conditions with 2.5% iodoacetamide. The equilibrated IPG strips were electrophoresed for the second dimension using 12% acrylamide gels. Two dimensional gel electrophoresis was performed at four different pH ranges, viz., pH 3-10, 4-7, 5-8, and 7-10. After the 2D gel electrophoresis, the proteins were stained with SYPRO Ruby (BioRad). The images for the macula and peripheral retina were compared with ImageMaster 2D Platinum ver.5.0 (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) followed by visual inspection. The gel spots numbered in Fig. 1 were excised. Two dimensional gels of peripheral retina were stained with Bio-safe Coomassie (Bio-Rad).
Then, 46 spots from the Coomassie-stained gel were excised (Fig. 1, Peripheral Coomassie) .
In gel digestion and LC-MS/MS analyses
Each gel piece was cut into approximately one cubic millimeter and washed twice with 50 mM ammonium bicarbonate/50% acetonitrile. After destaining, the gel pieces were rinsed with distilled water, and incubated with acetonitrile for 20 min. The supernatant was discarded and the gel pieces were completely dried before incubation with 10 mM DTT in 100 mM ammonium bicarbonate for 45 min at 56°C. The supernatant was discarded and the pieces were incubated in the dark with 55 mM iodoacetamide in 100 mM ammonium bicarbonate (30 min, at room temperature). The supernatant was discarded, and the gels were washed three times. Finally, the gel pieces were completely dried before tryptic digestion in sequencing grade trypsin solution (12.5 ng/ µl; Promega, Madison, WI, USA) in 50 mM ammonium bicarbonate. The digestion was performed at 37°C overnight, and the extraction step was performed once with 25 mM ammonium bicarbonate, twice with 5% formic acid, and finally with distilled water. The extracted peptides were pooled and dried. After re-suspending in 40 µl of aqueous 0.01% trifluoroacetic acid/2% acetonitrile, the samples were analyzed by LC (liquid chromatography)-MS/MS. LC-MS/MS was performed with a combined Paradigm MS4 (Michrom BioResources, Auburn, CA, USA) and an ESI mass spectrometer (LCQ Deca XP plus or Finnigan LTQ, Thermo Fisher Scientific, Yokohama, Japan; assembled by AMR Inc., Tokyo, Japan). For the LCQ analysis, sample peptides were separated in nano column (AMR Inc.) with solvent A (2% acetonitrile/0.1% formic acid) and B (90% acetonitrile/0.1% formic acid) at flow rate of 0.6 µl/min, gradient of 5 to 95% solvent B over 40 min. For the LTQ analysis, peptides were separated on Magic C18 (Michrom BioResources) with solvent A and B, a flow rate 1.5 µl/min, gradient of 5 to 95% solvent B over 30 min. The identification of the proteins from the MS/MS spectra was performed using protein identification software (Bioworks ver.3.1, Thermo Fisher Scientific) and UniProtKB/Swiss-Prot database (Release 48.8) which was preliminarily extracted by the species "human" (13,361 entries). Peak list generation and database searches were performed with the following parameters: mass tolerance for precursor ions, 2.5 amu; mass tolerance for fragment ions, 0.00 amu; enzymatic cleavage position, after lysine or arginine; number of missed cleavage sites permitted, 2; fixed modification, carbamide-methylation (+57.02 Da) for cysteine; variable modification, oxidation (+16 Da) for methionine. The peptide sequences were filtered by delta Cn score and peptide Cross Correlation (XC) score. The threshold level of delta Cn scores was >0.1 for peptide sequences from both measurement devices. The threshold levels of XC scores for each charge (+1/+2/+3) were >1.5/2.0/3.7 for LCQ and >1.9/2.2/3.7 for LTQ. Then, the correlations between the observed in gel images and the theoretical molecular weight and pI were considered. When peptides matched multiple members of the protein family, the protein which had the most number of peptides that matched the amino acid sequence was selected. In case of equal numbers, both proteins were listed.
Western blotting and immunohistochemical analysis of macula
Five to fifteen micrograms of macula or peripheral retinal homogenates were diluted in a double volume of SDS buffer and separated by 1D-PAGE followed by transfer to PVDF (polyvinylidene difluoride) membrane. Membranes were blocked with blocking solution (Blocking Solution Concentrate, KPL, Gaithersburg, MD, USA), skim milk, or BSA dissolved in PBS and probed with one of the following primary antibodies (Abs): chicken Ab to human arrestin-C (GenWay Biotech, San Diego, CA, USA), rabbit Ab to human synuclein gamma (Novus Biologicals, Littleton, CO, USA), rat Ab to human epidermal fatty acid binding protein (E-FABP) (R&D Systems, Minneapolis, MN, USA), rabbit Ab to tropomyosin Br-1, Br-3 (CHEMICON International, Temecula, CA, USA), mouse Ab to chicken tropomyosin TM311 (Abcam, Cambridge, UK), and goat Ab to human heterogeneous nuclear ribonucleoproteins (hnRNPs) A2/ B1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The specific signals were detected with one of the following secondary antibodies: horseradish peroxidase (HRP)-conjugated goat Ab to mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA), HRP-conjugated goat Ab to rabbit IgG (Pierce, Rockford, IL, USA), HRP-conjugated rabbit Ab to chicken/turkey IgG (Zymed Laboratories, South San Francisco, CA, USA), HRP-conjugated donkey Ab to goat IgG (Jackson ImmunoResearch Laboratories), HRP-conjugated goat Ab to rat IgG (Zymed Laboratories). The signals were made visible by chemiluminescence reactions and examined with a chemiluminescence imager (Lumi-Imager F1; Roche Diagnostics, Tokyo, Japan). An enucleated eye from a normal female cynomolgus monkey (age 13 years) was fixed in 10% neutralized and buffered formaldehyde solution at 4°C overnight and then dehydrated. The specimens were embedded in paraffin and serially sectioned at 4 µm thickness. The specimens were treated for antigen retrieval by autoclaving in Target Retrieval Solution (Dako, Carpinteria, CA, USA) for 20 min at 121°C. The sections were then blocked with Dako Protein Block (Dako) or skim milk or BSA in PBS. The primary antibodies were the same as used for the western blotting, and rabbit Ab to human platelet/endothelial cell adhesion molecule (PECAM1) (Proteintech Grroup, Chicago, IL, USA). For signal detection after rinsing off the primary antibodies, the sections were incubated with one of following secondary antibodies: Alexa 488-conjugated goat Ab to anti-mouse IgG, Alexa 568-conjugated goat Ab to anti-mouse IgG, Alexa 488-conjugated goat Ab to anti-rabbit IgG, Alexa 568-conjugated goat Ab to anti-rabbit IgG, Alexa 488-conjugated donkey Ab to anti-goat IgG, Alexa 568-conjugated goat Ab to antichicken IgG, and Alexa 488-conjugated goat Ab to antirat IgG (all secondary antibodies from Invitrogen, Tokyo, Japan). After rinsing off the antibodies, the sections were examined by confocal laser scanning microscope (Radiance 2100, Bio-Rad). The cell nuclei were stained with DAPI (4',6-diamino-2-phenylindole). To determine the location of the signals, one of the sections was stained with hematoxylin and eosin.
Results
Identification of macula enriched proteins
Approximately 700 spots were detected in the macular and peripheral retinal tissues in the 2D gel stained with SYPRO Ruby (pH range 3-10; Fig. 1A ). Sixty percent of these spots were found in both samples. Butt et al. have described the difficulties of IEF separation by RNAlater contaminations [4] . Our samples were de- Fig. 1 . Separation of monkey retina proteins on 2D gels. Proteins extracted from the peripheral retina and macula (300 µg each) were isoelectric focused at four different pH ranges; pH 3-10 (A), 4-7 (B), 5-8 (C), 7-10 (D). Then the IPG strips were separated on 12% SDS-page gels and stained by SYPRO Ruby. Forty spots marked by spot IDs were unique to the macula gel images and identified by LC-MS/MS. Boxed areas (a-f, Peripheral-SYPRO Ruby; a'-f', Macula-SYPRO Ruby) correspond to the enlarged images in Fig. 2 . Two dimensional gels of peripheral retina were also stained by Bio-safe Coomassie. Forty-six spots marked by spot number were identified by LC-MS/MS. salted prior to the IEF separation by Ready Prep 2D cleanup kit using TCA (trichloroacetic acid) acetone precipitation which resulted in successful separations. To obtain a further separation, the pH range of the 2D gel electrophoresis was narrowed to three ranges; 4-7, 5-8, and 7-10 ( Fig. 1B-D) . Among gel images for both the macula and peripheral retina, fluorescence from spots of abundant proteins were saturated and showed indistinct spot boundaries. Excess proteins contained in the samples were not concentrated at one spot by 2D gel electrophoresis and showed streaking and outliers. To exclude these proteins which were identified from seemingly macular specific spots, abundant proteins were identified. To clarify the outline of saturated spots, gels of peripheral retina were stained with Bio-safe Coomassie. Forty-nine proteins were identified from forty-six spots in the Coomassie stained gel image of the pH 3-10 range (Fig. 1A , Peripheral Coomassie). The proteins are listed in Table  1 . Forty-eight known proteins from earlier proteomic studies of the retina were identified [1, 5, 15, 49, 50] . The neurofilament triplet L protein identified in our study has not been previously identified by the proteomic approach but it has been reported in a SAGE analysis [35] . The 49 proteins were expressed in both the macula and peripheral retina, while 26 proteins were identified from 40 spots in macula gel images (Table 2) . Twenty-three of these were also reported in previous proteomic studies of the retina [1, 5, 10, 15, 22, 50] . The other three proteins are known to be ubiquitously expressed in cells [8, 11] . Therefore, these proteins were not macula specific but widely expressed in the retina.
Validation of macula enriched proteins
To obtain the relative expression levels of the identified proteins, western blot analysis was performed on the following five proteins identified by mass spectrometry: tropomyosin 1 α chain ( Fig. 2A and 2E ), g-synuclein (Fig. 2B ), E-FABP (Fig. 2C) , arrestin-C (Fig. 2D) , and hnRNPs A2/B1 (Fig. 2F) . Arrestin-C has been identified as a cone photoreceptor-specific protein [33] , and thus served as a positive control for this study. g-Synuclein is a protein known to be up-regulated in cancer cells [20] . hnRNPs A2/B1 is also known to be up-regulated in carcinoma cells [42] . E-FABP is a reactive lipid scavenger [2] . Four proteins, including arrestin-C, were confirmed to have higher expression in the macula by western blotting. Tropomyosin 1 α chain has been reported to have many isoforms by alternative splicing [34] . MS/MS data from spot M2 (Fig.1A , Macula SY-PRO Ruby) identified the peptide sequence CAEL-EEELK, which corresponded to isoform 1 (skeletal muscle type) or isoform 5 (brain type, TMBr-3) of tropomyosin 1 α chain in the UniProtKB/Swiss-Prot database. Based on these data, western blotting was performed using two antibodies for tropomyosin 1 α chain. The anti-tropomyosin antibody TM311 detects 19 amino acids in exon 1a of the tropomyosin gene family in mammalian tissues, viz., alpha-, beta-, gamma-, delta-tropomyosin, including the skeletal muscle type but it does not detect the brain type (TMBr-3), because TMBr-3 doesn't contain exon 1a in transcription sequence. The other antibodies used were specific to the brain isoforms TMBr-1 and TMBr-3 [34] . Signals of TMBr-1 were not detected in samples from the two retinal regions by western blotting (data not shown). The signals of TMBr-3 were not significantly different, and the signals to TM311 were found to be different between the two regions.
Tissue localization of macula enriched proteins
To determine the location of the 5 proteins in the macula, immunohistochemistry was performed using antibodies against each protein (Fig. 3) . Arrestin-C was detected in photoreceptor outer segments and the outer plexiform layer (Fig. 3B ) as previously reported [33] . g-Synuclein was detected in RGCs in the nerve fiber layer (Fig. 3D) , which confirms the result of a previous study [43] . E-FABP was predominantly detected in the outer plexiform layer and external limiting membrane, which exists between the outer nuclear layer and the photoreceptor layer (Fig. 3G) . Our observation is consistent with that of an earlier study by Kingma et al. reporting the localization of E-FABP to Müller cells [21] , which are dense in the parafovea [7] . hnRNPs A2/B1 was located in the nucleus of cells in the retinal ganglion cell layer, the inner nuclear layer, the outer nuclear layer, and the RPE with different intensities (Fig. 3E) . TM311 was detected in the choroidal layer (Fig. 3F) , while tropomyosin Br-3 was located in photoreceptor inner segments and the outer plexiform layer (Fig. 3C) . To determine the localization of tropomyosin detected by TM311 Fig. 1 (Peripheral-Coomassie) .
b) Accession No. corresponds to UniProtKB/ Swiss-prot database.
c) MW and pI are theoretical scores. in the choroidal layer more specifically, sections were labeled with anti-PECAM1 antibody (Fig. 3H) . PECAM1 is an adhesion molecule expressed at intercellular junctions between vascular endothelial cells [24] (Fig. 3J and 3K, green). Tropomyosin detected by TM311 (red) was expressed adjacent to PECAM1 (Fig. 3I and 3K ).
Discussion
In this study, we identified and validated of proteins expressed in the macula and peripheral retina. The method, 2D gel electrophoresis, limits detection to proteins in aqueous soluble form. Nevertheless, a number of proteins highly expressed in the macula were found.
One of the identified proteins was arrestin-C, which is known to be highly expressed in cone photoreceptors, which are densely located in the primate macula [6] . Previous SAGE analyses of the retina by Bowes Rickman et al. [3] have shown 1.4-fold higher transcription of arrestin-C in the macula compared to the peripheral retina in humans. Another protein that was identified in macular unique spots was 3'(2'),5'-bisphosphate nucleotidase 1 (Table 2, M3) , which has also been identified by SAGE as being highly expressed in cone photoreceptors [3] . Identification of these cone photoreceptor rich proteins indicates that the present proteomic analysis was methodologically effective for identifying proteins richly expressed in the macula. It also suggests the higher protein level in the macula may be due to a higher density of specific cell types expressing specific proteins. Previous studies have shown arrestin-C expression in cones [33] , g-synuclein expression in RGCs [43] , and E-FABP expression in Müller cells [21] . Although these proteins have been identified in not only specific cell types or compartments in the retina [1, 10, 15, 22, 50] , the majority were localized in particular cell layers in the retina (Fig. 3B, 3D , and 3G). In a comparative transcription study of macular and peripheral RPE, expression of E-FABP was 6.3-fold higher in the peripheral RPE compared to macular RPE in middle-aged humans [48] . Our immunostaining showed predominant localization of E-FABP in the neural retina, except the photoreceptors (Fig. 3G) , which is consistent with the results of Kingma et al. [21] . Our observation of higher E-FABP expression in the macula is due to higher expression by the neural retina, not the RPE.
Immunostaining revealed hnRNPs A2/B1 was present in every retinal nucleus layer (Fig. 3E) . However, western blots showed higher expression of hnRNPs A2/B1 in the macula than in the peripheral retina (Fig. 2F ). This may be explained by a higher concentration of RGC layers, where hnRNPs A2/B1 is preferentially expressed, in the macular region (Fig. 3E) . hnRNPs A2/B1 was identified in several horizontal 2D gel spots (Fig. 1D , box. f') indicating the possibility of multiple phosphorylation sites for this protein. Phosphorylation of hnRNPs A2/B1 has been shown to be essential for the myelination of the axon-glia connection [51] . A similar myelination role is expected for hnRNPs A2/B1 in the RGCs.
In this study, two types of antibodies for tropomyosin isoforms were used. The brain-type isoform of tropomyosin detected by TMBr-3 antibody was not differentially expressed between the macula and peripheral retina ( Fig. 2A) , however tropomyosin detected by TM311 antibody showed remarkably higher expression in the macula (Fig. 2E) . The difference in the expression level of the TM311-detected isoforms of tropomyosin resulted in an additional spot in the macula 2D gel which did not react with the TMBr-3 antibody. The TMBr-3-detected isoform is expressed in all regions of the brain [12, 41] and also in the outer plexiform layer and photoreceptor inner segments of the retina (Fig. 3C) . This is in contrast to arrestin-C expression, which is limited to the photoreceptor outer segment (Fig. 3B) . This is the first report to localize the brain-type isoform of tropomyosin in photoreceptors.
TM311 detected isoforms were localized to vascular endothelial cells compared to the localization of PE-CAM1 in choroid layer (Fig. 3H) . Abundant expression of tropomyosin 1 α chain in the macula may arise from the higher capillary density in the choroidal layer of the fovea [30] . An earlier study, using human umbilical vein endothelial cells exposed to hydrogen peroxide, showed an increase in phosphorylation of tropomyosin through the activation of the extracellular signal-regulated kinase (ERK) pathway. Inhibition of the ERK pathway results in disruption of the endothelial layer and a two-fold increase in transendothelial permeability [17] . Tropomyosin has been previously described to interact with two anti-angiogenic factors, endostatin, a cleaved fragment of collagen XVIII [23] , and high molecular weight kininogen [52] . Both proteins exhibit anti-angiogenic effect by binding to tropomyosin. Thus, tropomyosin may play an inhibitory role in increasing permeability or angiogenesis in the macula. Angiogenesis is a pathological finding often observed in the advanced stage of AMD [13] .
In summary, 26 gel spots were identified as unique to the macula and 5 of these proteins were also confirmed by western blot as being richly expressed in the macula. Differential expression is likely due to morphological differences between the macula and the peripheral retina. The retina of macaque monkeys is almost identical to that of humans. Further understanding of these proteins should provide valuable information about the onset and progression of macular diseases in humans.
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